InvestorsObserver
×
News Home

Is Bioatla Inc (BCAB) a Leader in the Biotechnology Industry?

Monday, April 01, 2024 12:48 PM | InvestorsObserver Analysts

Mentioned in this article

Is Bioatla Inc (BCAB) a Leader in the Biotechnology Industry?

The 75 rating InvestorsObserver gives to Bioatla Inc (BCAB) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 88 percent of stocks in the Biotechnology industry, BCAB’s 75 overall rating means the stock scores better than 75 percent of all stocks.

Overall Score - 75
BCAB has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on BCAB!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 75 would rank higher than 75 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Bioatla Inc Stock Today?

Bioatla Inc (BCAB) stock has gained 1.6% while the S&P 500 is lower by -0.27% as of 12:29 PM on Monday, Apr 1. BCAB is up $0.05 from the previous closing price of $3.44 on volume of 555,494 shares. Over the past year the S&P 500 is higher by 27.05% while BCAB is up 23.67%. BCAB lost -$2.58 per share the over the last 12 months. Click Here to get the full Stock Report for Bioatla Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App